Benshoof Klein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA clears Otsuka, Click s prescription app for depression

FDA clears Otsuka, Click s prescription app for depression
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Brian iacovielloDavid benshoof kleinMount sinai icahn school of medicineClick therapeuticsBenshoof kleinProject baselineMount sinaiIcahn schoolEmotional faces memory task

Smartphone app approved as treatment for depression 5 things to know about Rejoyn

It is “designed to act like physical therapy for the brain,” a scientific advisor says.

New yorkUnited statesDavid benshoof kleinJohn torousBrian iacovielloDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskMount sinaiDigital psychiatryBeth israel deaconess medical centerBenshoof kleinMajor depressive disorderFood and drug administrationEgions of the brain

Smartphone app approved as treatment for depression 5 things to know about Rejoyn

It is “designed to act like physical therapy for the brain,” a scientific advisor says.

New yorkUnited statesJohn torousDavid benshoof kleinBrian iacovielloDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskMount sinaiDigital psychiatryBeth israel deaconess medical centerBenshoof klein

David B Klein, Author at MedCity News

David B Klein, Author at MedCity News
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

David benshoof kleinDavidb kleinStern school of businessColumbia business schoolBiotechnology program at columbia universityBenshoof kleinBiotechnology programColumbia universityColumbia businessManaging directorOpus point partnersSenior consultantWeight lossMedical devicesHealthcare innovationMedcity news

DTx company Click Therapeutic scores $52M in Series B funding

This news comes roughly a year after the company signed a $500 million deal with Boehringer Ingelheim.

David benshoof kleinBoehringer ingelheimHealth catalyst capitalClick therapeuticBiohealth partnersAccelmed partnersRevelation partnersShima venturesClick neurobehavioral interventionBenshoof kleinProject baseline